HUI HU: Open Payments
NPI 1548986276 · NORWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,735 in 379 payments from 20 companies in 2025. Trend: 2023 $5,563 · 2024 $5,445 · 2025 $7,735
Food & beverage: $7,711Education: $24
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 73 | $1,251 |
| E.R. Squibb & Sons, L.L.C. | 49 | $820 |
| Axsome Therapeutics, Inc. | 43 | $755 |
| Teva Pharmaceuticals USA, Inc. | 24 | $625 |
| Neurocrine BioSciences, Inc. | 22 | $586 |
| ABBVIE INC. | 29 | $526 |
| Alkermes, Inc. | 18 | $446 |
| Janssen Pharmaceuticals, Inc | 10 | $388 |
| Vanda Pharmaceuticals Inc. | 17 | $381 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $287 |
Products named: CAPLYTA, COBENFY, INGREZZA, VRAYLAR, REXULTI, Auvelity, UZEDY, FANAPT.
Industry payments across CT — which companies pay providers there.
